Clarity on Close the Gap Co-payment initiative Some Aboriginal and Torres Strait Islander patients are being incorrectly told they are no longer able to register for the PBS-subsidised program.
Health Minister confirms NPS MedicineWise cuts Despite appeals to overturn a decision under the previous Government to remove funding from NPS MedicineWise, the original decision will stand.
‘Not sustainable’: Medicine shortages in focus The Government is being urged to shore up pharmaceutical supply chains to avoid ‘problematic’ disruptions to patient care.
Navigating the recent growth in asthma medications The National Asthma Council Australia has launched new resources to help inform health professions about treatment options.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
Concern over significant NPS MedicineWise changes The recent budget revealed a ‘redesign’ for stewarding the quality use of medicines, with major implications for the organisation.
Thousands expected to benefit from new PBS listings Medications for asthma, HIV, and Crohn’s disease have been added, while some heart, cholesterol and blood pressure drugs are now cheaper.
Do homeopathy clinical trials lead to reporting bias? Dr Carolyn Ee examines newly released evidence on the efficacy of homeopathy.
NPS MedicineWise partnership to strengthen the role of GPs The collaboration builds on a shared goal of improving quality use of medicines, clinical decision making and general practice education.
Which medicines could be in short supply in 2022? The pandemic has proven time and time again that it is a potent driver of shortages – but the end of COVID-induced medicine supply issues may come sooner than expected.